<DOC>
	<DOCNO>NCT00992732</DOCNO>
	<brief_summary>The purpose study determine treatment HQK-1004 valganciclovir result complete partial response patient EBV-positive lymphoid malignancy lymphoproliferative disorder .</brief_summary>
	<brief_title>Study HQK-1004 Valganciclovir Treat Epstein-Barr Virus ( EBV ) - Positive Lymphoid Malignancies Lymphoproliferative Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Lymphoproliferative Disorders</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<mesh_term>Arginine butyrate</mesh_term>
	<criteria>Histologically confirm lymphoid malignancy lymphoproliferative disorder EBV detect either immunohistochemistry situ hybridization . Pathology assess either current previous biopsy . All disease stag eligible Disease refractory relapse least one prior standard therapeutic regimen , include biologic agent ( e.g. , monoclonal antibody ) , chemotherapy chemoradiotherapy regimen . Prior therapy may include high dose chemotherapy stem cell rescue bone marrow transplantation Bidimensionally measurable disease computerize tomography ( CT ) magnetic resonance imaging ( MRI ; patient sensitivity contrast tumor type less accurately measure CT ) scan physical measurement ( cutaneous lesion ) least 1 lesion ≥ 10 mm great diameter . PETCT use baseline patient Hodgkin 's Disease ( HD ) diffuse large Bcell lymphoma ( DLBCL ) . Absolute neutrophil count ≥ 500/mm3 platelet count ≥ 50,000/mm3 Bilirubin ≤ 2.0 time upper limit normal ( ULN ) exception patient Gilbert 's syndrome ( bilirubin ≤ 3.5 time ULN allow ) , AST ALT ≤ 3 time ULN Serum creatinine ≤ 2.0 mg/dL Patients recover previous treatment chemotherapy Patients treat biologic agent within two week prior first dose HQK1004 Uncontrolled ischemic heart disease uncontrolled congestive heart failure , myocardial infarction within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>